1. Ludwig, J., Viggiano, T. R., McGill, D. B., & Oh, B. J. (1980). Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings, 55(7), 434–438.
2. Definition & Facts of NAFLD & NASH | NIDDK [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases. Retrieved January 29, 2021, from https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/definition-facts
3. Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357.
4. Cholankeril, G., Wong, R. J., Hu, M., Perumpail, R. B., Yoo, E. R., Puri, P., et al. (2017). Liver Transplantation for nonalcoholic steatohepatitis in the US: Temporal trends and outcomes. Digestive Diseases and Sciences, 62(10), 2915–2922.
5. Wong, R. J., Aguilar, M., Cheung, R., Perumpail, R. B., Harrison, S. A., Younossi, Z. M., et al. (2015). Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology, 148(3), 547–555.